JP2012508027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508027A5 JP2012508027A5 JP2011535765A JP2011535765A JP2012508027A5 JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5 JP 2011535765 A JP2011535765 A JP 2011535765A JP 2011535765 A JP2011535765 A JP 2011535765A JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5
- Authority
- JP
- Japan
- Prior art keywords
- cadherin
- seq
- diabody
- cells
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11304208P | 2008-11-10 | 2008-11-10 | |
| US61/113,042 | 2008-11-10 | ||
| PCT/US2009/063881 WO2010054377A2 (en) | 2008-11-10 | 2009-11-10 | Fully human antibodies against n-cadherin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508027A JP2012508027A (ja) | 2012-04-05 |
| JP2012508027A5 true JP2012508027A5 (enExample) | 2012-12-20 |
Family
ID=42153647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535765A Pending JP2012508027A (ja) | 2008-11-10 | 2009-11-10 | Ｎ−カドヘリンに対する完全ヒト抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8703920B2 (enExample) |
| EP (1) | EP2356145A4 (enExample) |
| JP (1) | JP2012508027A (enExample) |
| KR (1) | KR20110084309A (enExample) |
| CN (1) | CN102300873A (enExample) |
| AU (1) | AU2009313239A1 (enExample) |
| BR (1) | BRPI0921457A2 (enExample) |
| CA (1) | CA2743122A1 (enExample) |
| CO (1) | CO6362022A2 (enExample) |
| IL (1) | IL212795A0 (enExample) |
| MX (1) | MX2011004945A (enExample) |
| RU (1) | RU2011123655A (enExample) |
| WO (1) | WO2010054377A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663635B2 (en) | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| WO2007109347A2 (en) * | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and ly6 e: targets for cancer diagnosis and therapy |
| KR20100132998A (ko) * | 2008-04-04 | 2010-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 종양 성장, 혈관신생 및 전이를 차단하는 것을 목표로 하는 암에 대한 항체 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
| GB201119089D0 (en) | 2011-11-04 | 2011-12-21 | Isis Innovation | Treatment of musculoskeletal fibroproliferative disorders |
| EP2830659A1 (en) | 2012-03-27 | 2015-02-04 | Novartis AG | Treatment of fibrosis |
| CN107076160B (zh) * | 2014-08-21 | 2019-12-20 | 江森自控科技公司 | 电池监测系统 |
| US20200165351A1 (en) * | 2017-06-06 | 2020-05-28 | The Regents Of The University Of California | Humanized anti-n-cadherin antibodies and uses thereof |
| EP4337702A1 (en) * | 2021-05-13 | 2024-03-20 | Wuxi Biologics Ireland Limited | Antibody conjugate comprising anti-p-cadherin antibody and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889157A (en) | 1990-10-12 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Humanized B3 antibody fragments, fusion proteins, and uses thereof |
| AU669124B2 (en) | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
| US6680175B2 (en) | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
| US6277824B1 (en) | 1998-07-10 | 2001-08-21 | Adherex Technologies | Compounds and methods for modulating adhesion molecule function |
| WO2001062206A2 (en) | 2000-02-22 | 2001-08-30 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
| US20030190602A1 (en) | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| DK1629011T3 (da) * | 2003-05-31 | 2010-05-03 | Micromet Ag | Humane anti-humane-DC3-bindingsmolekyler |
| US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
| AU2006259583A1 (en) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20100278821A1 (en) | 2006-03-21 | 2010-11-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| US8663635B2 (en) | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| WO2007109347A2 (en) | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and ly6 e: targets for cancer diagnosis and therapy |
| KR20100132998A (ko) | 2008-04-04 | 2010-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 종양 성장, 혈관신생 및 전이를 차단하는 것을 목표로 하는 암에 대한 항체 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
-
2009
- 2009-11-09 US US12/590,601 patent/US8703920B2/en not_active Expired - Fee Related
- 2009-11-10 KR KR1020117013339A patent/KR20110084309A/ko not_active Withdrawn
- 2009-11-10 EP EP09825592A patent/EP2356145A4/en not_active Withdrawn
- 2009-11-10 JP JP2011535765A patent/JP2012508027A/ja active Pending
- 2009-11-10 AU AU2009313239A patent/AU2009313239A1/en not_active Abandoned
- 2009-11-10 RU RU2011123655/10A patent/RU2011123655A/ru unknown
- 2009-11-10 BR BRPI0921457A patent/BRPI0921457A2/pt not_active Application Discontinuation
- 2009-11-10 CA CA2743122A patent/CA2743122A1/en not_active Abandoned
- 2009-11-10 MX MX2011004945A patent/MX2011004945A/es unknown
- 2009-11-10 CN CN2009801544698A patent/CN102300873A/zh active Pending
- 2009-11-10 WO PCT/US2009/063881 patent/WO2010054377A2/en not_active Ceased
-
2011
- 2011-05-09 IL IL212795A patent/IL212795A0/en unknown
- 2011-06-08 CO CO11070983A patent/CO6362022A2/es not_active Application Discontinuation
-
2013
- 2013-06-17 US US13/919,652 patent/US20140017240A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508027A5 (enExample) | ||
| CN110536900B (zh) | 调节补体依赖性细胞溶解效应子功能的修饰的人igm恒定区 | |
| CN105837688B (zh) | 单域抗体及其编码基因，免疫毒素及其编码基因、制备方法、表达载体、应用，及宿主细胞 | |
| CN106117354B (zh) | 一种全人源抗CD47的全分子IgG抗体及其应用 | |
| RU2009118621A (ru) | Агонистические антитела против notch3 и их применение для лечения ntch3-ассоциированных заболеваний | |
| JP2003510366A (ja) | Ａｐｒｉｌレセプター（ｂｃｍａ）およびその使用 | |
| KR101671955B1 (ko) | 항 ＴＮＦ-α/ＣＸＣＬ10 이중 타겟 항체 및 그의 용도 | |
| CN113480657B (zh) | 针对her2的单域抗体及其衍生蛋白和应用 | |
| CN109206514A (zh) | Tslp单克隆抗体及其制备方法和应用 | |
| TWI688575B (zh) | 阻礙血管內皮脂酶之酵素活性的人類化單株抗體 | |
| CN109705225B (zh) | 一种抗人caix抗原的嵌合抗原受体及其应用 | |
| WO2003106499A1 (ja) | 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット | |
| CN113321721B (zh) | 一种细胞外Ezrin蛋白及其应用 | |
| CN115058430B (zh) | 一种拟穴青蟹5-ht2受体基因及其应用 | |
| CA2323091A1 (en) | Nephrin gene and protein | |
| CN117866903B (zh) | 单域抗体修饰的干细胞及其在疾病治疗中用途 | |
| CN101544695B (zh) | 人源化抗cd25单链抗体及制备方法 | |
| JP6574033B2 (ja) | Ｗｎｔ蛋白質の製造方法および保存方法 | |
| KR20100118900A (ko) | 사이토케라틴１７―특이적인 인간항체 | |
| CN117866902A (zh) | 具有抗il-17a活性的基因修饰干细胞及其制备方法以及药物组合物 | |
| CN110117325B (zh) | 一种猪cd127多肽及其编码基因和应用 | |
| JP3288716B2 (ja) | ヒト接着分子オクルディン | |
| CN107686519A (zh) | 抗小鼠mxra7单克隆抗体的制备方法及其应用 | |
| CN120040594B (zh) | 一种靶向flt3基因编辑通用型car-t细胞的制备方法和应用 | |
| CN120005027B (zh) | 大口黑鲈cd6抗原结合肽、及其单克隆抗体和应用 |